Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study (Q35905994)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 June 2014

edit

Language	Label	Description	Also known as
English	Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study	scientific article published on 15 June 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

title

Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

main subject

multicenter clinical trial

0 references

author name string

Steven L Flamm

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

Paul J Pockros

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

Leif Bengtsson

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

Mark Friedman

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

publication date

15 June 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

published in

Journal of clinical and translational hepatology

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

volume

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

page(s)

65-73

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

cites work

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Response-guided telaprevir combination treatment for hepatitis C virus infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Telaprevir for Retreatment of HCV Infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

A methodology for conducting retrospective chart review research in child and adolescent psychiatry

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

27 July 2018

Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

The one-person randomized controlled trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

Retrospective studies and chart reviews.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4521261

retrieved

24 September 2018

Panel 1: methodological issues in pharmacoeconomic evaluations--clinical studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26356545

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26356545

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.14218/JCTH.2014.00007

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

PMC publication ID

4521261

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

PubMed publication ID

26356545

1 reference

stated in

Europe PubMed Central

PMC publication ID

4521261

retrieved

11 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35905994&oldid=1604974291"